People exposed to Ebola are placed under a 21‑day monitoring period, the virus’s incubation window, during which health workers conduct daily symptom checks for fever, headache, muscle pain, weakness, vomiting and diarrhoea.

If an exposed individual remains symptom‑free for the full 21 days, counted from the last possible exposure, they may be released from monitoring once public‑health conditions are satisfied.

Confirmed Ebola patients must be clinically stable and produce two consecutive negative polymerase chain reaction (PCR) test results, with samples taken 48 to 72 hours apart, before they can be declared cleared for discharge.

PCR testing detects the virus’s genetic material and is essential because Ebola symptoms overlap with illnesses such as malaria, making laboratory confirmation critical before discharge.

Patients receive supportive care—including intravenous fluids, nutritional support and oxygen when needed—while clinicians monitor for complications and follow treatment guidelines specific to the Ebola strain involved.

After discharge, survivors may still carry viral material in certain body fluids; national guidance may require additional testing and counselling on post‑recovery precautions.

The ministry stresses follow‑up care, psychological support and clear communication to reduce stigma and help survivors reintegrate safely into the community.

As of October 15, Kenya recorded two confirmed Ebola cases and one death; 108 contacts were in quarantine while five were traced outside the country, and efforts to locate the remaining contacts continued.

Health workers continue to wear appropriate protective equipment and follow strict safety procedures to minimise infection risk, and the ministry reported no evidence of wider community transmission.